272 related articles for article (PubMed ID: 23421589)
1. Rational discovery of dengue type 2 non-competitive inhibitors.
Heh CH; Othman R; Buckle MJ; Sharifuddin Y; Yusof R; Rahman NA
Chem Biol Drug Des; 2013 Jul; 82(1):1-11. PubMed ID: 23421589
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease.
Liu H; Wu R; Sun Y; Ye Y; Chen J; Luo X; Shen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(22):6344-52. PubMed ID: 25438757
[TBL] [Abstract][Full Text] [Related]
3. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
[TBL] [Abstract][Full Text] [Related]
4. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
5. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
7. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G
J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671
[TBL] [Abstract][Full Text] [Related]
8. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
9. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition.
Mukhametov A; Newhouse EI; Aziz NA; Saito JA; Alam M
J Mol Graph Model; 2014 Jul; 52():103-13. PubMed ID: 25023665
[TBL] [Abstract][Full Text] [Related]
10. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
[TBL] [Abstract][Full Text] [Related]
15. Allosteric inhibition of the NS2B-NS3 protease from dengue virus.
Yildiz M; Ghosh S; Bell JA; Sherman W; Hardy JA
ACS Chem Biol; 2013 Dec; 8(12):2744-52. PubMed ID: 24164286
[TBL] [Abstract][Full Text] [Related]
16. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential hit compounds for Dengue virus NS2B/NS3 protease inhibitors by combining virtual screening and binding free energy calculations.
Wichapong K; Nueangaudom A; Pianwanit S; Sippl W; Kokpol S
Trop Biomed; 2013 Sep; 30(3):388-408. PubMed ID: 24189670
[TBL] [Abstract][Full Text] [Related]
19. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]